ID   FAK1_RAT                Reviewed;        1055 AA.
AC   O35346; Q62900;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   02-OCT-2024, entry version 215.
DE   RecName: Full=Focal adhesion kinase 1 {ECO:0000305};
DE            Short=FADK 1;
DE            EC=2.7.10.2;
DE   AltName: Full=Focal adhesion kinase-related nonkinase;
DE            Short=FRNK;
DE   AltName: Full=Protein-tyrosine kinase 2;
DE   AltName: Full=p125FAK;
DE   AltName: Full=pp125FAK;
GN   Name=Ptk2 {ECO:0000312|RGD:3443}; Synonyms=Fak, Fak1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=Sprague-Dawley; TISSUE=Corpus striatum;
RX   PubMed=8738136; DOI=10.1016/0169-328x(95)00273-u;
RA   Burgaya F., Girault J.A.;
RT   "Cloning of focal adhesion kinase, pp125FAK, from rat brain reveals
RT   multiple transcripts with different patterns of expression.";
RL   Brain Res. Mol. Brain Res. 37:63-73(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 350-528 (ISOFORM 1).
RC   STRAIN=Wistar;
RA   Sasaki T., Nagura K., Sasaki H.;
RL   Submitted (DEC-1995) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   INTERACTION WITH TGFB1I1.
RX   PubMed=9422762; DOI=10.1074/jbc.273.2.1003;
RA   Matsuya M., Sasaki H., Aoto H., Mitaka T., Nagura K., Ohba T., Ishino M.,
RA   Takahashi S., Suzuki R., Sasaki T.;
RT   "Cell adhesion kinase beta forms a complex with a new member, Hic-5, of
RT   proteins localized at focal adhesions.";
RL   J. Biol. Chem. 273:1003-1014(1998).
RN   [4]
RP   SUBCELLULAR LOCATION, PHOSPHORYLATION AT SER-722 AND SER-913, AND
RP   CHARACTERIZATION OF ISOFORM 2.
RX   PubMed=12732587; DOI=10.1161/01.hyp.0000072772.74183.5f;
RA   Yi X.P., Wang X., Gerdes A.M., Li F.;
RT   "Subcellular redistribution of focal adhesion kinase and its related
RT   nonkinase in hypertrophic myocardium.";
RL   Hypertension 41:1317-1323(2003).
RN   [5]
RP   INTERACTION WITH ARHGEF28.
RX   PubMed=12702722; DOI=10.1074/jbc.m302381200;
RA   Zhai J., Lin H., Nie Z., Wu J., Canete-Soler R., Schlaepfer W.W.,
RA   Schlaepfer D.D.;
RT   "Direct interaction of focal adhesion kinase with p190RhoGEF.";
RL   J. Biol. Chem. 278:24865-24873(2003).
RN   [6]
RP   SUMOYLATION AT LYS-152, MUTAGENESIS OF LYS-152, INTERACTION WITH PIAS1,
RP   AUTOPHOSPHORYLATION, PHOSPHORYLATION AT TYR-397, AND SUBCELLULAR LOCATION.
RX   PubMed=14500712; DOI=10.1074/jbc.m308562200;
RA   Kadare G., Toutant M., Formstecher E., Corvol J.C., Carnaud M.,
RA   Boutterin M.C., Girault J.A.;
RT   "PIAS1-mediated sumoylation of focal adhesion kinase activates its
RT   autophosphorylation.";
RL   J. Biol. Chem. 278:47434-47440(2003).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH DCC.
RX   PubMed=15494733; DOI=10.1038/nn1330;
RA   Ren X.R., Ming G.L., Xie Y., Hong Y., Sun D.M., Zhao Z.Q., Feng Z.,
RA   Wang Q., Shim S., Chen Z.F., Song H.J., Mei L., Xiong W.C.;
RT   "Focal adhesion kinase in netrin-1 signaling.";
RL   Nat. Neurosci. 7:1204-1212(2004).
RN   [8]
RP   SUBCELLULAR LOCATION, PHOSPHORYLATION, AND CHARACTERIZATION OF ISOFORM 2.
RX   PubMed=16373587; DOI=10.1152/ajpheart.00659.2005;
RA   Yi X.P., Zhou J., Huber L., Qu J., Wang X., Gerdes A.M., Li F.;
RT   "Nuclear compartmentalization of FAK and FRNK in cardiac myocytes.";
RL   Am. J. Physiol. 290:H2509-H2515(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-576; SER-913 AND TYR-928, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Non-receptor protein-tyrosine kinase that plays an essential
CC       role in regulating cell migration, adhesion, spreading, reorganization
CC       of the actin cytoskeleton, formation and disassembly of focal adhesions
CC       and cell protrusions, cell cycle progression, cell proliferation and
CC       apoptosis. Required for early embryonic development and placenta
CC       development. Required for embryonic angiogenesis, normal cardiomyocyte
CC       migration and proliferation, and normal heart development. Regulates
CC       axon growth and neuronal cell migration, axon branching and synapse
CC       formation; required for normal development of the nervous system. Plays
CC       a role in osteogenesis and differentiation of osteoblasts. Functions in
CC       integrin signal transduction, but also in signaling downstream of
CC       numerous growth factor receptors, G-protein coupled receptors (GPCR),
CC       EPHA2, netrin receptors and LDL receptors. Forms multisubunit signaling
CC       complexes with SRC and SRC family members upon activation; this leads
CC       to the phosphorylation of additional tyrosine residues, creating
CC       binding sites for scaffold proteins, effectors and substrates.
CC       Regulates numerous signaling pathways. Promotes activation of
CC       phosphatidylinositol 3-kinase and the AKT1 signaling cascade. Promotes
CC       activation of MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling
CC       cascade. Promotes localized and transient activation of guanine
CC       nucleotide exchange factors (GEFs) and GTPase-activating proteins
CC       (GAPs), and thereby modulates the activity of Rho family GTPases.
CC       Signaling via CAS family members mediates activation of RAC1.
CC       Phosphorylates NEDD9 following integrin stimulation (By similarity).
CC       Recruits the ubiquitin ligase MDM2 to P53/TP53 in the nucleus, and
CC       thereby regulates P53/TP53 activity, P53/TP53 ubiquitination and
CC       proteasomal degradation. Phosphorylates SRC; this increases SRC kinase
CC       activity. Phosphorylates ACTN1, ARHGEF7, GRB7, RET and WASL. Promotes
CC       phosphorylation of PXN and STAT1; most likely PXN and STAT1 are
CC       phosphorylated by a SRC family kinase that is recruited to
CC       autophosphorylated PTK2/FAK1, rather than by PTK2/FAK1 itself. Promotes
CC       phosphorylation of BCAR1; GIT2 and SHC1; this requires both SRC and
CC       PTK2/FAK1. Promotes phosphorylation of BMX and PIK3R1.
CC       {ECO:0000250|UniProtKB:P34152, ECO:0000250|UniProtKB:Q05397,
CC       ECO:0000269|PubMed:15494733}.
CC   -!- FUNCTION: [Isoform 2]: Does not contain a kinase domain and inhibits
CC       PTK2/FAK1 phosphorylation and signaling. Its enhanced expression can
CC       attenuate the nuclear accumulation of LPXN and limit its ability to
CC       enhance serum response factor (SRF)-dependent gene transcription (By
CC       similarity). {ECO:0000250|UniProtKB:Q05397}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- ACTIVITY REGULATION: Subject to autoinhibition, mediated by
CC       interactions between the FERM domain and the kinase domain. Activated
CC       by autophosphorylation at Tyr-397. This promotes interaction with SRC
CC       and phosphorylation at Tyr-576 and Tyr-577 in the kinase activation
CC       loop by SRC. Phosphorylation at Tyr-397, Tyr-576 and Tyr-577 is
CC       required for maximal kinase activity.
CC   -!- SUBUNIT: Interacts with GIT1. Component of a complex that contains at
CC       least FER, CTTN and PTK2/FAK1. Interacts with BMX. Interacts with
CC       STEAP4. Interacts with ZFYVE21. Interacts with ESR1. Interacts with
CC       PIK3R1 or PIK3R2. Interacts with FGR, FLT4 and RET. Interacts with
CC       EPHA2 in resting cells; activation of EPHA2 recruits PTPN11, leading to
CC       dephosphorylation of PTK2/FAK1 and dissociation of the complex.
CC       Interacts with EPHA1 (kinase activity-dependent). Interacts with
CC       P53/TP53. Interacts (via first Pro-rich region) with CAS family members
CC       (via SH3 domain), including BCAR1, BCAR3, and CASS4. Interacts with
CC       NEDD9 (via SH3 domain) (By similarity). Interacts with TGFB1I1.
CC       Interacts with SRC, GRB2 and GRB7. Interacts with ARHGEF28. Interacts
CC       with SHB. Part of a complex composed of THSD1, PTK2/FAK1, TLN1 and VCL
CC       (By similarity). Interacts with PXN and TLN1. Interacts with SORBS1.
CC       Interacts with STAT1. Interacts with WASL. Interacts with ARHGAP26 and
CC       SHC1. Interacts with RB1CC1; this inhibits PTK2/FAK1 activity and
CC       activation of downstream signaling pathways. Interacts with ARHGEF7.
CC       Interacts with MDM2 (By similarity). Interacts with PIAS1. Interacts
CC       with DCC. Interacts with LPXN (via LD motif 3) (By similarity).
CC       Interacts with MISP (By similarity). Interacts with EMP2; regulates
CC       PTK2 activation and localization (By similarity). Interacts with DSCAM
CC       (By similarity). Interacts with AMBRA1 (By similarity). Interacts (when
CC       tyrosine-phosphorylated) with tensin TNS1; the interaction is increased
CC       by phosphorylation of TNS1 (By similarity).
CC       {ECO:0000250|UniProtKB:P34152, ECO:0000250|UniProtKB:Q05397}.
CC   -!- INTERACTION:
CC       O35346; Q6P6T5: Ocln; NbExp=2; IntAct=EBI-6252940, EBI-15348891;
CC       O35346; O35346: Ptk2; NbExp=12; IntAct=EBI-6252940, EBI-6252940;
CC       O35346; Q5XI86: Ptrh2; NbExp=3; IntAct=EBI-6252940, EBI-6252926;
CC   -!- SUBCELLULAR LOCATION: Cell junction, focal adhesion
CC       {ECO:0000250|UniProtKB:Q00944}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q00944}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q00944}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:Q00944}. Cytoplasm, perinuclear region
CC       {ECO:0000250|UniProtKB:Q00944}. Cytoplasm, cell cortex. Cytoplasm,
CC       cytoskeleton {ECO:0000269|PubMed:12732587}. Cytoplasm, cytoskeleton,
CC       microtubule organizing center, centrosome {ECO:0000250}. Nucleus
CC       {ECO:0000269|PubMed:12732587, ECO:0000269|PubMed:14500712,
CC       ECO:0000269|PubMed:16373587}. Cytoplasm, cytoskeleton, cilium basal
CC       body {ECO:0000250|UniProtKB:Q05397}. Cytoplasm
CC       {ECO:0000269|PubMed:16373587}. Note=Constituent of focal adhesions.
CC       Detected at microtubules. {ECO:0000250|UniProtKB:P34152}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage; Named isoforms=2;
CC       Name=1;
CC         IsoId=O35346-1; Sequence=Displayed;
CC       Name=2; Synonyms=FRNK;
CC         IsoId=O35346-2; Sequence=VSP_042172;
CC   -!- DOMAIN: The first Pro-rich domain interacts with the SH3 domain of CAS
CC       family members, such as BCAR1 and NEDD9. {ECO:0000250}.
CC   -!- DOMAIN: The C-terminal region is the site of focal adhesion targeting
CC       (FAT) sequence which mediates the localization of FAK1 to focal
CC       adhesions.
CC   -!- PTM: Phosphorylated on tyrosine residues upon activation, e.g. upon
CC       integrin signaling. Tyr-397 is the major autophosphorylation site, but
CC       other kinases can also phosphorylate this residue. Phosphorylation at
CC       Tyr-397 promotes interaction with SRC and SRC family members, leading
CC       to phosphorylation at Tyr-576, Tyr-577 and at additional tyrosine
CC       residues. FGR promotes phosphorylation at Tyr-397 and Tyr-576. FER
CC       promotes phosphorylation at Tyr-577, Tyr-861 and Tyr-928, even when
CC       cells are not adherent. Tyr-397, Tyr-576 and Ser-722 are phosphorylated
CC       only when cells are adherent. Phosphorylation at Tyr-397 is important
CC       for interaction with BMX, PIK3R1 and SHC1. Phosphorylation at Tyr-928
CC       is important for interaction with GRB2. Dephosphorylated by PTPN11;
CC       PTPN11 is recruited to PTK2 via EPHA2 (tyrosine phosphorylated).
CC       Microtubule-induced dephosphorylation at Tyr-397 is crucial for the
CC       induction of focal adhesion disassembly; this dephosphorylation could
CC       be catalyzed by PTPN11 and regulated by ZFYVE21 (By similarity).
CC       Phosphorylation on tyrosine residues is enhanced by NTN1 (By
CC       similarity). {ECO:0000250|UniProtKB:P34152}.
CC   -!- PTM: Sumoylated; this enhances autophosphorylation.
CC       {ECO:0000269|PubMed:12732587, ECO:0000269|PubMed:14500712,
CC       ECO:0000269|PubMed:16373587}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. FAK subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF020777; AAB72203.1; -; mRNA.
DR   EMBL; U43942; AAA86280.1; -; mRNA.
DR   RefSeq; NP_037213.1; NM_013081.2. [O35346-1]
DR   AlphaFoldDB; O35346; -.
DR   SMR; O35346; -.
DR   BioGRID; 247643; 7.
DR   CORUM; O35346; -.
DR   DIP; DIP-41330N; -.
DR   IntAct; O35346; 6.
DR   MINT; O35346; -.
DR   STRING; 10116.ENSRNOP00000075518; -.
DR   BindingDB; O35346; -.
DR   ChEMBL; CHEMBL5773; -.
DR   iPTMnet; O35346; -.
DR   PhosphoSitePlus; O35346; -.
DR   jPOST; O35346; -.
DR   PaxDb; 10116-ENSRNOP00000011219; -.
DR   PeptideAtlas; O35346; -.
DR   GeneID; 25614; -.
DR   KEGG; rno:25614; -.
DR   UCSC; RGD:3443; rat. [O35346-1]
DR   AGR; RGD:3443; -.
DR   CTD; 5747; -.
DR   RGD; 3443; Ptk2.
DR   VEuPathDB; HostDB:ENSRNOG00000007916; -.
DR   eggNOG; KOG4257; Eukaryota.
DR   HOGENOM; CLU_002646_0_0_1; -.
DR   InParanoid; O35346; -.
DR   OrthoDB; 1614410at2759; -.
DR   PhylomeDB; O35346; -.
DR   BRENDA; 2.7.10.2; 5301.
DR   Reactome; R-RNO-111465; Apoptotic cleavage of cellular proteins.
DR   Reactome; R-RNO-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-RNO-354192; Integrin signaling.
DR   Reactome; R-RNO-354194; GRB2:SOS provides linkage to MAPK signaling for Integrins.
DR   Reactome; R-RNO-372708; p130Cas linkage to MAPK signaling for integrins.
DR   Reactome; R-RNO-375165; NCAM signaling for neurite out-growth.
DR   Reactome; R-RNO-3928662; EPHB-mediated forward signaling.
DR   Reactome; R-RNO-418885; DCC mediated attractive signaling.
DR   Reactome; R-RNO-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-RNO-5663213; RHO GTPases Activate WASPs and WAVEs.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-RNO-8874081; MET activates PTK2 signaling.
DR   Reactome; R-RNO-9009391; Extra-nuclear estrogen signaling.
DR   PRO; PR:O35346; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000007916; Expressed in lung and 19 other cell types or tissues.
DR   ExpressionAtlas; O35346; baseline and differential.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:RGD.
DR   GO; GO:0005938; C:cell cortex; IEA:UniProtKB-SubCell.
DR   GO; GO:0005813; C:centrosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0036064; C:ciliary basal body; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0043197; C:dendritic spine; IDA:SynGO.
DR   GO; GO:0005925; C:focal adhesion; IDA:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0014704; C:intercalated disc; IDA:RGD.
DR   GO; GO:0030027; C:lamellipodium; ISO:RGD.
DR   GO; GO:0016604; C:nuclear body; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0098794; C:postsynapse; IDA:SynGO.
DR   GO; GO:0042383; C:sarcolemma; IDA:RGD.
DR   GO; GO:0001725; C:stress fiber; ISO:RGD.
DR   GO; GO:0003779; F:actin binding; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005178; F:integrin binding; IPI:RGD.
DR   GO; GO:0008432; F:JUN kinase binding; ISO:RGD.
DR   GO; GO:0140677; F:molecular function activator activity; ISO:RGD.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; ISS:UniProtKB.
DR   GO; GO:0019902; F:phosphatase binding; IDA:RGD.
DR   GO; GO:0043548; F:phosphatidylinositol 3-kinase binding; IPI:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0019903; F:protein phosphatase binding; ISO:RGD.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; ISS:UniProtKB.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0042169; F:SH2 domain binding; ISO:RGD.
DR   GO; GO:0001525; P:angiogenesis; ISO:RGD.
DR   GO; GO:0007409; P:axonogenesis; ISO:RGD.
DR   GO; GO:0001568; P:blood vessel development; ISO:RGD.
DR   GO; GO:0016477; P:cell migration; ISO:RGD.
DR   GO; GO:0071315; P:cellular response to morphine; IEP:RGD.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; ISO:RGD.
DR   GO; GO:0021955; P:central nervous system neuron axonogenesis; ISO:RGD.
DR   GO; GO:0043542; P:endothelial cell migration; ISO:RGD.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0030198; P:extracellular matrix organization; ISO:RGD.
DR   GO; GO:0045444; P:fat cell differentiation; IEP:RGD.
DR   GO; GO:0060396; P:growth hormone receptor signaling pathway; ISO:RGD.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IDA:SynGO.
DR   GO; GO:0030644; P:intracellular chloride ion homeostasis; IMP:RGD.
DR   GO; GO:0007254; P:JNK cascade; IMP:RGD.
DR   GO; GO:0000165; P:MAPK cascade; IMP:RGD.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; ISO:RGD.
DR   GO; GO:2000811; P:negative regulation of anoikis; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0010507; P:negative regulation of autophagy; ISO:RGD.
DR   GO; GO:0050771; P:negative regulation of axonogenesis; ISO:RGD.
DR   GO; GO:0030336; P:negative regulation of cell migration; IMP:RGD.
DR   GO; GO:0022408; P:negative regulation of cell-cell adhesion; ISO:RGD.
DR   GO; GO:0046621; P:negative regulation of organ growth; ISO:RGD.
DR   GO; GO:0051964; P:negative regulation of synapse assembly; ISO:RGD.
DR   GO; GO:0001764; P:neuron migration; ISO:RGD.
DR   GO; GO:0007097; P:nuclear migration; ISO:RGD.
DR   GO; GO:0035265; P:organ growth; ISO:RGD.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; ISS:UniProtKB.
DR   GO; GO:0010613; P:positive regulation of cardiac muscle hypertrophy; ISO:RGD.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; IMP:RGD.
DR   GO; GO:0030307; P:positive regulation of cell growth; IMP:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0010634; P:positive regulation of epithelial cell migration; ISO:RGD.
DR   GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; ISO:RGD.
DR   GO; GO:0010763; P:positive regulation of fibroblast migration; ISO:RGD.
DR   GO; GO:0060252; P:positive regulation of glial cell proliferation; IMP:RGD.
DR   GO; GO:0010759; P:positive regulation of macrophage chemotaxis; ISO:RGD.
DR   GO; GO:0120041; P:positive regulation of macrophage proliferation; ISO:RGD.
DR   GO; GO:0050766; P:positive regulation of phagocytosis; IMP:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISS:UniProtKB.
DR   GO; GO:0045860; P:positive regulation of protein kinase activity; ISS:UniProtKB.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0014911; P:positive regulation of smooth muscle cell migration; IMP:RGD.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:0050806; P:positive regulation of synaptic transmission; IMP:RGD.
DR   GO; GO:2000060; P:positive regulation of ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0090303; P:positive regulation of wound healing; ISO:RGD.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0030155; P:regulation of cell adhesion; IBA:GO_Central.
DR   GO; GO:0033628; P:regulation of cell adhesion mediated by integrin; ISS:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0008360; P:regulation of cell shape; ISS:UniProtKB.
DR   GO; GO:0010632; P:regulation of epithelial cell migration; ISO:RGD.
DR   GO; GO:0051893; P:regulation of focal adhesion assembly; ISO:RGD.
DR   GO; GO:1905274; P:regulation of modification of postsynaptic actin cytoskeleton; ISO:RGD.
DR   GO; GO:0045667; P:regulation of osteoblast differentiation; ISS:UniProtKB.
DR   GO; GO:0001932; P:regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:1900024; P:regulation of substrate adhesion-dependent cell spreading; ISO:RGD.
DR   GO; GO:0046685; P:response to arsenic-containing substance; IEP:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0009749; P:response to glucose; IEP:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0007172; P:signal complex assembly; IEA:InterPro.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; ISO:RGD.
DR   GO; GO:0001570; P:vasculogenesis; ISO:RGD.
DR   GO; GO:0042311; P:vasodilation; IMP:RGD.
DR   CDD; cd14473; FERM_B-lobe; 1.
DR   CDD; cd13190; FERM_C_FAK1; 1.
DR   CDD; cd05056; PTKc_FAK; 1.
DR   Gene3D; 1.20.80.10; -; 1.
DR   Gene3D; 1.20.120.330; Nucleotidyltransferases domain 2; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   Gene3D; 1.20.5.540; Single helix bin; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR019749; Band_41_domain.
DR   InterPro; IPR041390; FADK_N.
DR   InterPro; IPR049385; FAK1-like_FERM_C.
DR   InterPro; IPR041784; FAK1/PYK2_FERM_C.
DR   InterPro; IPR014352; FERM/acyl-CoA-bd_prot_sf.
DR   InterPro; IPR035963; FERM_2.
DR   InterPro; IPR019748; FERM_central.
DR   InterPro; IPR000299; FERM_domain.
DR   InterPro; IPR036137; Focal_adhe_kin_target_dom_sf.
DR   InterPro; IPR005189; Focal_adhesion_kin_target_dom.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   PANTHER; PTHR46221; FERM AND PDZ DOMAIN-CONTAINING PROTEIN FAMILY MEMBER; 1.
DR   PANTHER; PTHR46221:SF8; NON-SPECIFIC PROTEIN-TYROSINE KINASE; 1.
DR   Pfam; PF21477; FERM_C_FAK1; 1.
DR   Pfam; PF00373; FERM_M; 1.
DR   Pfam; PF18038; FERM_N_2; 1.
DR   Pfam; PF03623; Focal_AT; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00295; B41; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF68993; FAT domain of focal adhesion kinase; 1.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   SUPFAM; SSF47031; Second domain of FERM; 1.
DR   SUPFAM; SSF54236; Ubiquitin-like; 1.
DR   PROSITE; PS00661; FERM_2; 1.
DR   PROSITE; PS50057; FERM_3; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative promoter usage; Angiogenesis; ATP-binding;
KW   Cell junction; Cell membrane; Cell projection; Cytoplasm; Cytoskeleton;
KW   Developmental protein; Isopeptide bond; Kinase; Membrane;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Transferase; Tyrosine-protein kinase; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q05397"
FT   CHAIN           2..1055
FT                   /note="Focal adhesion kinase 1"
FT                   /id="PRO_0000088079"
FT   DOMAIN          35..355
FT                   /note="FERM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00084"
FT   DOMAIN          422..680
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..29
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          685..734
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          707..1055
FT                   /note="Interaction with TGFB1I1"
FT                   /evidence="ECO:0000250"
FT   REGION          837..923
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          915..1055
FT                   /note="Interaction with ARHGEF28"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        9..25
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        866..880
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        546
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         428..434
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         454
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         500..502
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:Q05397"
FT   MOD_RES         5
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q05397"
FT   MOD_RES         13
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q05397"
FT   MOD_RES         29
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q05397"
FT   MOD_RES         54
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P34152"
FT   MOD_RES         397
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:14500712"
FT   MOD_RES         407
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q05397"
FT   MOD_RES         570
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q05397"
FT   MOD_RES         576
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         577
FT                   /note="Phosphotyrosine; by RET and SRC"
FT                   /evidence="ECO:0000250|UniProtKB:Q05397"
FT   MOD_RES         580
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q05397"
FT   MOD_RES         722
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:12732587"
FT   MOD_RES         732
FT                   /note="Phosphoserine; by CDK5"
FT                   /evidence="ECO:0000250|UniProtKB:P34152"
FT   MOD_RES         843
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q05397"
FT   MOD_RES         861
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q05397"
FT   MOD_RES         913
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:12732587,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         917
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q05397"
FT   MOD_RES         928
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CROSSLNK        152
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000269|PubMed:14500712"
FT   VAR_SEQ         1..692
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_042172"
FT   MUTAGEN         152
FT                   /note="K->R: Abolishes sumoylation."
FT                   /evidence="ECO:0000269|PubMed:14500712"
SQ   SEQUENCE   1055 AA;  119717 MW;  3AFB4ED682D14A33 CRC64;
     MAAAYLDPNL NHTPSSSTKT HLGTGTERSP GAMERVLKVF HYFESSNEPT TWASIIRHGD
     ATDVRGIIQK IVDSHKVKHV ACYGFRLSHL RSEEVHWLHV DMGVSSVREK YELAHPPEEW
     KYELRIRYLP KGFLNQFTED KPTLNFFYQQ VKSDYMLEIA DQVDQDIALK LGCLEIRRSY
     WEMRGNALEK KSNYEVLEKD VGLKRFFPKS LLDSVKAKTL RKLIQQTFRQ FANLNREESI
     LKFFEILSPV YRFDKECFKC ALGSSWIISV ELAIGPEEGI SYLTDKGCNP THLADFNQVQ
     TIQYSNSEDK DRKGMLQLKI AGAPEPLTVT APSLTIAENM ADLIDGYCRL VNGATQSFII
     RPQKEGERAL PSIPKLANNE KQGMRTHAVS VSETDDYAEI IDEEDTYTMP STRDYEIQRE
     RIELGRCIGE GQFGDVHQGV YLSPENPALA VAIKTCKNCT SDSVREKFLQ EALTMRQFDH
     PHIVKLIGVI TENPVWIIME LCTLGELRSF LQVRKYSLDL ASLILYAYQL STALAYLESK
     RFVHRDIAAR NVLVSSNDCV KLGDFGLSRY MEDSTYYKAS KGKLPIKWMA PESINFRRFT
     SASDVWMFGV CMWEILMHGV KPFQGVKNND VIGRIENGER LPMPPNCPPT LYSLMTKCWA
     YDPSRRPRFT ELKAQLSTIL EEEKVQQEER MRMESRRQAT VSWDSGGSDE APPKPSRPGY
     PSPRSSEGFY PSPQHMVQTN HYQISGYPGS HGIPAMAGSI YPGQASLLDQ TELWNHRPQE
     MSMWQPSVED SAALDLRGMG QVLPPHLMEE RLIRQQQEME EDQRWLEKEE RFLKPDVRLS
     RGSIDREDGS FQGPTGNQHI YQPVGKPDPA APPKKPPRPG APGHLSNLSS ISSPAESYNE
     GVKPWRLQPQ EISPPPTANL DRSNDKVYEN VTGLVKAVIE MSSKIQPAPP EEYVPMVKEV
     GLALRTLLAT VDETIPILPA STHREIEMAQ KLLNSDLGEL ISKMKLAQQY VMTSLQQEYK
     KQMLTAAHAL AVDAKNLLDV IDQARLKMLG QTRPH
//
